Impaired Protein Expression in Monocytes from Type 1 Diabetes Patients
Author Information
Author(s): Gabriele Wehrwein, Markus Neumeier, Andreas Schäffler, Andrea Kopp, Johanna Weigert, Sabine Abke, Jürgen Schölmerich, Christa Buechler
Primary Institution: Department of Internal Medicine I, University of Regensburg, Germany
Hypothesis
The study investigates how lipopolysaccharide (LPS) affects protein expression in monocytes from type 1 diabetes (T1D) patients compared to controls.
Conclusion
LPS-mediated protein expression is only partly disturbed in monocytes from T1D patients, with reduced secretion of IL-6 and CCL2 potentially contributing to an impaired inflammatory response.
Supporting Evidence
- IL-6 secretion was significantly reduced in T1D monocytes compared to controls.
- CCL2 secretion was also lower in T1D monocytes after LPS stimulation.
- CXCL8 and Apo E secretion were similar in both T1D and control monocytes.
Takeaway
The study found that monocytes from people with type 1 diabetes don't respond as well to certain signals that help fight infections, which might make them more prone to heart problems.
Methodology
Monocytes were isolated from blood samples of 10 female controls and 10 female T1D patients, and their response to LPS was analyzed for various cytokines and proteins.
Potential Biases
Potential bias due to the small sample size and the specific demographic of participants.
Limitations
The study only included female participants and may not represent the responses of male patients.
Participant Demographics
10 female controls and 10 female T1D patients, median age of controls was 24 years and T1D patients was 36.5 years.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website